Clinical trials: Unprotected Sex

Emergency Contraception

Safety and Efficacy of CDB-2914 for Emergency Contraception

• Completed
• Age: 18 years and older
• Phase 3
• Results posted

The purpose of this study is to assess the safety and efficacy of CDB-2914 for preventing pregnancy when taken 3 to 5 days after unprotected sexual intercourse.

Trial name

NCT00411684

Testing

CDB-2914

Where

17 sites in United States

Volunteers

1,623 people

Sponsor

HRA Pharma